Almeida-PoradaGDAscensăoJL.Cytomegalovirus as a cause of pancytopenia. Leuk Lymphoma. 1996;21(3-4):217-223.
6.
LuckSEWieringaJWBlázquez-GameroD, et al. Congenital cytomegalovirus: a European expert consensus statement on diagnosis and management. Pediatr Infect Dis J. 2017;36(12):1205-1213.
7.
WalstonFMcDevittKWalterSLuckSHolland-BrownT.Clinical Guideline: Diagnosis and Management of Congenital Cytomegalovirus. Cambridge: NHS England; 2017.
8.
KimberlinDWAcostaEPSánchezPJ, et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008;197(6):836-845.
9.
Children’s Health Queensland Hospital and Health Service. Treatment guideline for infants with congenital CMV Disease (cCMV). South Brisbane, QLD, Australia: Children’s Health Queensland Hospital and Health Service; 2023.
10.
KimberlinDW. Ganciclovir (DHPG, Cytovene, GCV) and valganciclovir (Valcyte, VGCV). In: LongSSPickeringLKProberCG, eds. Principles and Practice of Pediatric Infectious Diseases. 3rd ed. Philadelphia: Saunders; 2008.
11.
Kassur-SiemieńskaBSAIdzikMMilewska-BobulaB. Hematologic disorders in children with congenital cytomegalovirus infection. Pediatria Polska. 2005;80(10):880-885.